These data demonstrate that the overexpression of mGluR5 in the PrL altered the behavioral coping strategy to aversive events without alteration of basal activeness, and implies that this treatment made animals more vulnerable to depression and anxiety. Here, GRM5 is linked to depressive symptom measurement.